Boehringer Ingelheim

boehringer-ingelheim.com · Ingelheim am Rhein, Germany

Boehringer Ingelheim is a global research-driven pharmaceutical company that develops, manufactures, and markets prescription medicines, animal health products, and biopharmaceuticals. It serves patients, healthcare providers, and veterinarians worldwide across therapeutic areas such as respiratory, cardiovascular, oncology, immunology, and metabolic diseases. The company generates revenue through the sale of branded human pharmaceuticals, animal health products, and contract biopharmaceutical manufacturing services.

Revenue
$25.0B
Employees
53,000
Founded
1885
Headquarters
Ingelheim am Rhein, Germany

What 12 Arbolus experts think of Boehringer Ingelheim

NPS is distinctly high, with 45% of experts giving NPS scores of 10 and an additional 36% scoring 8-9. 77% of respondents with spend data over $1M would renew. Nearly all customers are in 'More Than 1 Year' implementation stage, reflecting strong stickiness. Positive themes are driven by satisfaction with product value and reliability.Overall Customer Sentiment: Positive

Who reviewed Boehringer Ingelheim

Total customers 12 11 current · 1 former
Reviews growth +6 in six months
Seniority of respondents
  • C-Suite 91% (11)
  • Manager 9% (1)
Marketing Leader C-Suite NPS 5
Product Leader Manager NPS 8 Will renew
Revenue Leader C-Suite NPS 8 Will renew

Employer names and spend open once the report publishes.

Tell us when the Boehringer Ingelheim report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Notify me

Sentiment

41 Net Promoter Score, from 12 scored reviews
  • Promoters 6
  • Passives 5
  • Detractors 1

Cumulative NPS by month

+0 over 6 months
  • Jan 8
  • Feb 8
  • Apr 8
  • May 8
  • Jul 8
  • Aug 8

Net Promoter Score across 3 reviews, accumulated up to each month. Category median 41 across 3 companies.

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 78%
  • Will renew 7
  • Undecided 2
  • Not renewing 0

Plan to renew, by seniority

  • C-Suite 86% 7 answers
  • Manager 100% 1 answer
  • Not specified 0% 1 answer
  • 9/10 Average score from customers who will renew
  • 7.5/10 Average score from undecided customers

Top alternatives

Most weighed by Boehringer Ingelheim customers

For people who use Boehringer Ingelheim

Do you use Boehringer Ingelheim at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 12 customers of Boehringer Ingelheim have already contributed
Share your experience

Takes a few minutes. Your identity stays anonymous.